Literature DB >> 31632538

LncRNA Blnc1 expression and its effect on renal fibrosis in diabetic nephropathy.

Xianzhen Feng1, Jin Zhao2, Jingjing Ding1, Xiaoyi Shen1, Jun Zhou1, Zhongqing Xu1.   

Abstract

BACKGROUND AND OBJECTIVES: Diabetic nephropathy (DN) is one of the commonest microvascular complications of diabetes and has been the major cause of end-stage renal disease in many countries. It is of great clinical significance to further explore more efficacious therapeutic strategies for DN. This study aims to explore the effect of Blnc1 on renal fibrosis in diabetic nephropathy.
METHODS: In this study, mRNA level of Blnc1 was examined by RT-PCR. HE staining and Masson staining were adopted to detect kidney damage and renal fibrosis. The renal fibrosis was evaluated by the levels of PTEN, fibronectin, collagen I and collagen IV with immunofluorescence assay and western blot analysis. Oxidative Stress and inflammatory response were detected by ELISA assay. At the same time, western blot was performed to detect the proteins related to NRF2/HO-1 and NF-κB pathways.
RESULTS: Blnc1 has higher expression in serum of DN patients, STZ-induced DN model and HG-induced HK2 cells. Blnc1 interference significantly attenuated renal fibrosis, inflammation and oxidative stress via NRF2/HO-1 and NF-κB pathways.
CONCLUSION: Our present study suggested that Blnc1 can affect inflammation, oxidative stress and renal fibrosis by Nrf2/HO-1 and NF-κB pathways in DN. AJTR
Copyright © 2019.

Entities:  

Keywords:  LncRNA Blnc1; diabetic nephropathy; renal fibrosis

Year:  2019        PMID: 31632538      PMCID: PMC6789252     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  23 in total

1.  PTEN loss defines a TGF-β-induced tubule phenotype of failed differentiation and JNK signaling during renal fibrosis.

Authors:  Rongpei Lan; Hui Geng; Aaron J Polichnowski; Prajjal K Singha; Pothana Saikumar; Donald G McEwen; Karen A Griffin; Robert Koesters; Joel M Weinberg; Anil K Bidani; Wilhelm Kriz; Manjeri A Venkatachalam
Journal:  Am J Physiol Renal Physiol       Date:  2012-02-01

Review 2.  Long non-coding RNAs: insights into functions.

Authors:  Tim R Mercer; Marcel E Dinger; John S Mattick
Journal:  Nat Rev Genet       Date:  2009-03       Impact factor: 53.242

3.  Loss of tumour suppressor PTEN expression in renal injury initiates SMAD3- and p53-dependent fibrotic responses.

Authors:  Rohan Samarakoon; Sevann Helo; Amy D Dobberfuhl; Nidah S Khakoo; Lucas Falke; Jessica M Overstreet; Roel Goldschmeding; Paul J Higgins
Journal:  J Pathol       Date:  2015-04-27       Impact factor: 7.996

Review 4.  Nrf2-Keap1 signaling in oxidative and reductive stress.

Authors:  Ilaria Bellezza; Ileana Giambanco; Alba Minelli; Rosario Donato
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2018-02-27       Impact factor: 4.739

Review 5.  Have we really demonstrated the cardiovascular safety of anti-hyperglycaemic drugs? Rethinking the concepts of macrovascular and microvascular disease in type 2 diabetes.

Authors:  Milton Packer
Journal:  Diabetes Obes Metab       Date:  2018-02-04       Impact factor: 6.577

6.  High glucose induces activation of NF-κB inflammatory signaling through IκBα sumoylation in rat mesangial cells.

Authors:  Wei Huang; Ling Xu; Xueqin Zhou; Chenlin Gao; Maojun Yang; Guo Chen; Jianhua Zhu; Lan Jiang; Huakui Gan; Fang Gou; Hong Feng; Juan Peng; Yong Xu
Journal:  Biochem Biophys Res Commun       Date:  2013-08-02       Impact factor: 3.575

Review 7.  Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy.

Authors:  Ting-Ting Wan; Xiu-Fen Li; Yan-Ming Sun; Yan-Bo Li; Ying Su
Journal:  Biomed Pharmacother       Date:  2015-08-13       Impact factor: 6.529

8.  LncRNA-NR_033515 promotes proliferation, fibrogenesis and epithelial-to-mesenchymal transition by targeting miR-743b-5p in diabetic nephropathy.

Authors:  Junjie Gao; Weisong Wang; Fangli Wang; Canghui Guo
Journal:  Biomed Pharmacother       Date:  2018-07-11       Impact factor: 6.529

9.  FOXO1 Overexpression Attenuates Tubulointerstitial Fibrosis and Apoptosis in Diabetic Kidneys by Ameliorating Oxidative Injury via TXNIP-TRX.

Authors:  Linlin Ji; Qingzhu Wang; Fengjuan Huang; Tingting An; Feng Guo; Yanyan Zhao; Yang Liu; Yanyan He; Yi Song; Guijun Qin
Journal:  Oxid Med Cell Longev       Date:  2019-03-06       Impact factor: 6.543

10.  The long noncoding RNA Blnc1 orchestrates homeostatic adipose tissue remodeling to preserve metabolic health.

Authors:  Xu-Yun Zhao; Siming Li; Jennifer L DelProposto; Tongyu Liu; Lin Mi; Cara Porsche; Xiaoling Peng; Carey N Lumeng; Jiandie D Lin
Journal:  Mol Metab       Date:  2018-06-08       Impact factor: 7.422

View more
  11 in total

1.  Expression of LncRNA KCNQ1Ot1 in diabetic nephropathy and its correlation with MEK/ERK signaling pathway.

Authors:  Xuangeng Huang; Junhua Tan; Yingrong Li; Hongye Su; Meiying Huang; Feifan Huang; Peng Huang
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

2.  SNHG15 knockdown inhibits diabetic nephropathy progression in pediatric patients by regulating the miR-141/ICAM-1 axis in vitro.

Authors:  Jiewei Liu; Dongliang Cai; Ying Wang; Yanhong Zou; Tana Zhao
Journal:  Biosci Rep       Date:  2021-02-26       Impact factor: 3.840

3.  LncRNA PVT1 Regulates High Glucose-Induced Viability, Oxidative Stress, Fibrosis, and Inflammation in Diabetic Nephropathy via miR-325-3p/Snail1 Axis.

Authors:  Baoyu Qin; Xiaoli Cao
Journal:  Diabetes Metab Syndr Obes       Date:  2021-04-19       Impact factor: 3.168

Review 4.  Transforming Growth Factor-β and Long Non-coding RNA in Renal Inflammation and Fibrosis.

Authors:  Yue-Yu Gu; Jing-Yun Dou; Xiao-Ru Huang; Xu-Sheng Liu; Hui-Yao Lan
Journal:  Front Physiol       Date:  2021-05-13       Impact factor: 4.566

Review 5.  LncRNAs: Novel Biomarkers for Pancreatic Cancer.

Authors:  Soudeh Ghafouri-Fard; Mohadeseh Fathi; Tianyue Zhai; Mohammad Taheri; Peixin Dong
Journal:  Biomolecules       Date:  2021-11-10

Review 6.  Long Non-Coding RNAs in the Pathogenesis of Diabetic Kidney Disease.

Authors:  Mengsi Hu; Qiqi Ma; Bing Liu; Qianhui Wang; Tingwei Zhang; Tongtong Huang; Zhimei Lv
Journal:  Front Cell Dev Biol       Date:  2022-04-20

Review 7.  The Impact of lncRNA on Diabetic Kidney Disease: Systematic Review and In Silico Analyses.

Authors:  Yunyun Zhao; Guanchi Yan; Jia Mi; Guoqiang Wang; Miao Yu; Di Jin; Xiaolin Tong; Xiuge Wang
Journal:  Comput Intell Neurosci       Date:  2022-04-27

8.  Berberine Acts on C/EBPβ/lncRNA Gas5/miR-18a-5p Loop to Decrease the Mitochondrial ROS Generation in HK-2 Cells.

Authors:  Jiang Xu; Linqing Liu; Lin Gan; Yuanyuan Hu; Ping Xiang; Yan Xing; Jie Zhu; Shandong Ye
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-30       Impact factor: 5.555

Review 9.  NRF2-Related Epigenetic Modifications in Cardiac and Vascular Complications of Diabetes Mellitus.

Authors:  Jie Wang; Mengjie Xiao; Jie Wang; Shudong Wang; Jingjing Zhang; Yuanfang Guo; Yufeng Tang; Junlian Gu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-25       Impact factor: 5.555

10.  LncRNA ARAP1-AS2 promotes high glucose-induced human proximal tubular cell injury via persistent transactivation of the EGFR by interacting with ARAP1.

Authors:  Xin Li; Tian-Kui Ma; Si Wen; Lu-Lu Li; Li Xu; Xin-Wang Zhu; Cong-Xiao Zhang; Nan Liu; Xu Wang; Qiu-Ling Fan
Journal:  J Cell Mol Med       Date:  2020-09-23       Impact factor: 5.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.